Somatic BRAF mutations have been detected in ~8% of human tumors including non-small cell lung cancer (NSCLC) (5%) and melanoma (~50%), whereas CRAF mutations are very rarely reported in cancer [1, 3]. Here, RAF1 is linked to non-small cell lung carcinoma.